Ginkgo Bioworks Holdings (DNA) Return on Capital Employed Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 807.00 |
| Dec 31, 2025 | 1,331.00 |
| Sep 30, 2025 | 1,302.00 |
| Jun 30, 2025 | 3,402.00 |
| Mar 31, 2025 | 1,890.00 |
| Dec 31, 2024 | 905.00 |
| Sep 30, 2024 | 198.00 |
| Jun 30, 2024 | -154.00 |
| Mar 31, 2024 | 1,967.00 |
| Dec 31, 2023 | 5,731.00 |
| Sep 30, 2023 | 15,656.00 |
| Jun 30, 2023 | 10,180.00 |
| Mar 31, 2023 | 5,192.00 |
| Dec 31, 2022 | -1,617.00 |
| Sep 30, 2022 | -19,183.00 |
| Jun 30, 2022 | -14,844.00 |